undefined,undefined,China China
In ***7, the company successfully obtained A round of financing, and invested in the establishment of A wholly-owned subsidiary, Jiangsu Aoya biotechnology co., ltd. in China pharmaceutical city, to comprehensively upgrade the research and development center and production base. At present, the company has 8,**0 square meters of production and development site, 1,**0 square meters of GMP workshop, more than *0 core patents authorized, more than *0 product registration certificates, the products have been sold to more than 5,**0 medical institutions in more than *0 provinces.
ビジネスタイプ
Manufacturing
ウェブサイト
www.pro-med.com.cn
設立年
2013
従業員数
101-500
主要市場
Worldwide
企業製品/サービス
covid 19 antibody test kit
工場所在地
Changping, Beijing, China
工場サイズ
5000 sqm to 10000 sqm
生産ライン数
8
年間総購買量の合計
1 - 2.5 Million USD
研究開発スタッフの人数
11 - 20 people
品質管理
In House
登記書
ISO13485:2016
契約製造
OEM Service Offered ,Buyer Label Offered
登録資本金
1 - 2.5 Million USD
所有権タイプ
Corporation Limited Liability Company
法定代表者/CEO
Zhanjiang Yu
エクスポートパーセンテージ
20%
年間売上高合計
2.5 - 10 Million USD
QCスタッフの人数
11 - 20 people
連絡先担当者
Lexy Wu
会社
Pro-med (Beijing) Technology Co., Ltd.
住所
undefined, undefined, China